FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to urology and oncology. A brachytherapy of prostate cancer is preceded by a transurethral prostatic resection. Tissues of an intermediate lobe of the prostate and prostatic gland are removed completely within a neck of the urinary bladder.
EFFECT: method enables reducing the volume of the prostatic gland before the impending brachytherapy, forming an optimal urethral lumen.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMBINATION THERAPY OF BENIGN PROSTATIC HYPERPLASIA OF LARGE DIMENSIONS IN AGED PATIENTS OR PATIENTS WITH MARKED INTERCURRENT PATHOLOGY | 2015 |
|
RU2585431C1 |
METHOD FOR SURGICAL CORRECTION OF RECURRENT BLADDER NECK STENOSIS | 2021 |
|
RU2773793C1 |
METHOD OF TREATING BENIGN HYPERPLASIA OF PROSTATE GLAND | 2012 |
|
RU2489093C1 |
METHOD FOR PREPARING PATIENT WITH URETHRA, WHICH RESECTOSCOPE CANNOT GO THROUGH, FOR TRANSURETHRAL RESECTION OF PROSTATE AND BLADDER | 2020 |
|
RU2749937C1 |
METHOD OF PROVIDING ACCESS TO A SURGICAL OBJECT WHEN PERFORMING PLASMA TRANSURETHRAL ENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2700488C1 |
METHOD OF DIAGNOSING PROSTATE CANCER IN PATIENTS AFTER ADENOMECTOMY | 2023 |
|
RU2812386C1 |
TREATMENT METHOD OF BENIGN HYPERPLASIA OF PROSTATE GLAND | 2008 |
|
RU2368408C1 |
METHOD FOR PREVENTING INJURY TO THE EXTERNAL URETHRAL SPHINCTER WHEN PERFORMING TRANSURETHRAL LASER ENUCLEATION OF BENIGN PROSTATIC HYPERPLASIA | 2021 |
|
RU2757678C1 |
METHOD FOR INTERMITTENT THERAPY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA | 2013 |
|
RU2531944C1 |
METHOD FOR VISUALIZING EFFICIENCY OF TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | 2018 |
|
RU2681508C1 |
Authors
Dates
2014-06-10—Published
2011-09-21—Filed